Skip to main content
SpringerLink
Log in

Mumps is Back: Why is Mumps Eradication Not Working?

  • Chapter
  • First Online:
Hot Topics in Infection and Immunity in Children VII

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 697))

Abstract

Mumps has been recognized as a common childhood illness since the time of Hippocrates in the fifth century BC. In 1790, central nervous system involvement was described by Hamilton and, in 1860, sensorineural deafness by Toynebee.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Habel K. Vaccination of human beings against mumps; vaccine administered at the start of an epidemic. I. Incidence and severity of mumps in vaccinated and control groups. Am J Hyg. 1951;54(3):295–311.

    CAS  PubMed  Google Scholar 

  2. World Health Organization. Mumps virus vaccines. Wkly Epidemiol Rec. 2007;82(7):51-60.

    Google Scholar 

  3. Fullerton KE, Reef SE. Commentary Ongoing debate over the safety of the different mumps vaccine strains impacts mumps disease control. Int J Epidemiol. 2002;31(5):983–4.

    Article  CAS  PubMed  Google Scholar 

  4. Health Protection Agency. Continued increase in mumps in universities 2008/2009 News; 2009 April. http://www.hpa.org.uk/hpr/archives/2009/news1409.htm

  5. Sartorius B, Penttinen P, Nilsson J, Johansen K, Jonsson K, Arneborn M et al. An outbreak of mumps in Sweden, Feb–Apr 2004. Euro Surveill. 2005;10(9):191–3. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=559.

    CAS  PubMed  Google Scholar 

  6. Karagiannis I, van Lier A, van Binnendijk R, Ruijs H, Ruijs H, Fanoy E et al. Mumps in a community with low vaccination coverage in the Netherlands. Euro Surveill. 2008;13(24). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18901.

    CAS  PubMed  Google Scholar 

  7. Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ. 2006;175(5):483–8.

    PubMed  Google Scholar 

  8. Aratchige PE, McIntyre PB, Quinn HE, Gilbert GL. Recent increases in mumps incidence in Australia: the “forgotten” age group in the 1998 Australian measles control campaign. Med J Aust. 2008;189(8):434–7.

    PubMed  Google Scholar 

  9. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580–9.

    Article  CAS  PubMed  Google Scholar 

  10. Vandermeulen C, Roelants M, Vermoere M, Roseeuw K, Goubau P, Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure? Vaccine. 2004;22(21–22):2713–16.

    Article  PubMed  Google Scholar 

  11. Peltola H, Jokinen S, Paunio M, Hovi T, Davidkin I. Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme. Lancet Infect Dis. 2008;8(12):796–803.

    Article  PubMed  Google Scholar 

  12. Vandermeulen C, Leroux-Roels G, Hoppenbrouwers K. Mumps outbreaks in highly vaccinated populations: What makes good even better?. Hum Vaccin. 2009;5(7):494–6.

    PubMed  Google Scholar 

  13. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999;77(1):3–14.

    CAS  PubMed  Google Scholar 

  14. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet. 2008;371(9616):932–44.

    Article  PubMed  Google Scholar 

  15. Agarwal T, Rahman N, Abel R. Down in the mumps. J Pediatr Surg. 2006;41(12):e17–18.

    Article  PubMed  Google Scholar 

  16. Hashimoto H, Fujioka M, Kinumaki H. An office-based prospective study of deafness in mumps. Pediatr Infect Dis J. 2009;28(3):173–5.

    Article  PubMed  Google Scholar 

  17. Baas MC, van Donselaar KA, Florquin S, van Binnendijk RS, ten Berge IJ, Bemelman FJ. Mumps: not an innocent bystander in solid organ transplantation. Am J Transplant. 2009;9(9):2186–9.

    Article  CAS  PubMed  Google Scholar 

  18. Plotkin SA, Rubin SA. Mumps vaccine. In: SA Plotkin WA Orenstein, PA Offit editors. Vaccines. 5th ed. Philadelphia, PA: Elsevier; 2008. p. 435–65.

    Google Scholar 

  19. Ornoy A, Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol. 2006;21(4):446–57.

    Article  CAS  PubMed  Google Scholar 

  20. Anderson LJ, Seward JF. Mumps epidemiology and immunity: the anatomy of a modern epidemic. Pediatr Infect Dis J. 2008;27(10 Suppl):S75–S79.

    PubMed  Google Scholar 

  21. Rubin SA, Amexis G, Pletnikov M, Li Z, Vanderzanden J, Mauldin J et al. . Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J Virol. 2003;77(21):11616–24.

    Article  CAS  PubMed  Google Scholar 

  22. Rubin SA, Afzal MA, Powell CL, Bentley ML, Auda GR, Taffs RE et al. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study. J Infect Dis. 2005;191(7):1123–8.

    Article  PubMed  Google Scholar 

  23. Johansson B, Tecle T, Orvell C. Proposed criteria for classification of new genotypes of mumps virus. Scand J Infect Dis. 2002;34(5):355–7.

    Article  PubMed  Google Scholar 

  24. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?. Clin Infect Dis. 2008;47(11):1458–67.

    Article  PubMed  Google Scholar 

  25. Friedman M, Hadari I, Goldstein V, Sarov I. Virus-specific secretory IgA antibodies as a means of rapid diagnosis of measles and mumps infection. Isr J Med Sci. 1983;19(10):881–4.

    CAS  PubMed  Google Scholar 

  26. Friedman MG. Radioimmunoassay for the detection of virus-specific IgA antibodies in saliva. J Immunol Methods. 1982;54(2):203–11.

    Article  CAS  PubMed  Google Scholar 

  27. Simpson RE. Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet. 1952;2(6734):549–54.

    Article  CAS  PubMed  Google Scholar 

  28. World Health Organization. WHO-recommended standards for surveillance of selected vaccine-preventable diseases Geneva; 2003. http://www.who.int/immunization_monitoring/diseases/mumps_surveillance/en/

  29. Davidkin I, Jokinen S, Paananen A, Leinikki P, Peltola H. Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella. J Infect Dis. 2005;191(5):719–23.

    Article  PubMed  Google Scholar 

  30. Brook I. Diagnosis and management of parotitis. Arch Otolaryngol Head Neck Surg. 1992;118(5):469–71.

    CAS  PubMed  Google Scholar 

  31. Bastien N, Bowness D, Burton L, Bontovics E, Winter AL, Tipples G et al. Parotitis in a child infected with triple-reassortant influenza A virus in Canada in 2007. J Clin Microbiol. 2009;47(6):1896–8.

    Article  PubMed  Google Scholar 

  32. Falk WA, Buchan K, Dow M, Garson JZ, Hill E, Nosal M et al. The epidemiology of mumps in southern Alberta 1980-1982. Am J Epidemiol. 1989;130(4):736–49.

    CAS  PubMed  Google Scholar 

  33. CDC (Atlanta) http://www.cdc.gov/ncphi/disss/nndss/casedef/mumps_2008.htm last accessed 10 Sep, 2009.

  34. Leland DS. Parainfluenza and mumps viruses. In: PR Murray, EJ Baron, JH Jorgensen, ML Landry and MA Pfaller (ed.). Manual of Clinical Microbiology. 2007; 9:1352–60; Washington, DC: ASM Press.

    Google Scholar 

  35. Krause CH, Eastick K, Ogilvie MM. Real-time PCR for mumps diagnosis on clinical specimens–comparison with results of conventional methods of virus detection and nested PCR. J Clin Virol. 2006;37:184–9.

    Article  CAS  PubMed  Google Scholar 

  36. Hatchette TF, Davidson R, Clay S, Pettipas J, LeBlanc J, Sarwal S, Smieja M, Forward KR. Laboratory diagnosis of mumps in a partially immunized population: The Nova Scotia Experience. Can J Infect Dis Med Microbiol. 2009;20(4):e157–e162.

    Google Scholar 

  37. CDC (Atlanta) http://www.cdc.gov/ncphi/disss/nndss/casedef/mumps_2008.htm last accessed 10 Sep 2009.

  38. Germann D, Gorgievski A, Strohle A, Matter L. Detection of mumps virus in clinical specimens by rapid centrifugation culture and conventional tube cell culture. J Virol Methods. 1998;73:59–64.

    Article  CAS  PubMed  Google Scholar 

  39. Uchida K, Shinohara M, Shimada S, Segawa Y, Doi R, Gotoh A, Hondo R. Rapid and sensitive detection of mumps virus RNA directly from clinical samples by real-time PCR. J Med Virol. 2005;75:470–4.

    Article  CAS  PubMed  Google Scholar 

  40. Jin L, Beard S, Brown DW. Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J Infect Dis. 1999;180:829–33.

    Article  CAS  PubMed  Google Scholar 

  41. Boddicker JD, Rota PA, Kreman T, Wangeman A, Lowe L, Hummel KB, Thompson R, Bellini WJ, Pentella M, Desjardin LE. Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens. J Clin Microbiol. 2007;45:2902–8.

    Article  CAS  PubMed  Google Scholar 

  42. Leblanc JJ, Pettipas J, Davidson RJ, Tipples GA, Hiebert J, Hatchette TF. Detection of mumps virus RNA by real-time one-step reverse transcriptase PCR using the LightCycler platform. J Clin Microbiol. 2008;46:4049–51.

    Article  CAS  PubMed  Google Scholar 

  43. Jin L, Feng Y, Parry R, Cui A, Real-time LuY. PCR and its application to mumps rapid diagnosis. J Med Virol. 2007;79:1761–7.

    Article  CAS  PubMed  Google Scholar 

  44. Krause CH, Molyneaux PJ, Ho-Yen DO, McIntyre P, Carman WE, Templeton. KE. J Clin Virol. 2007;38:153.

    Article  CAS  PubMed  Google Scholar 

  45. Rota JS, Turner JC, Yost-Daljev MK, Freeman M, Toney DM, Meisel E, Williams N, Sowers SB, Lowe L, Rota PA, Nicolai LA, Peake L, Bellini WJ. Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol. 2009;81:1819–25.

    Article  CAS  PubMed  Google Scholar 

  46. Pipkin PA, Afzal MA, Heath AB, Minor PD. Assay of humoral immunity to mumps virus. J Virol Methods. 1999;79:219–25.

    Article  CAS  PubMed  Google Scholar 

  47. Ballew HC. In: S Specter, RL Hodinka, SA Young editors. Neutralization in: clinical virology manual, 3rd ed. Washington, DC. ASM Press, 2000. p. 127–34.

    Google Scholar 

  48. Tipples GA, Beirnes J, Hiebert J, Hatchette T, Pettipas J, Macey J, Deeks S, Lipskie T, Bellini W, Rota P, Rota J Laboratory Guidelines for the diagnosis of mumps v.3 (3 Apr 2008) http://www.nml-lnm.gc.ca/guide/guideview-eng.asp?key=186 (Last accessed 10 Sep 2009:1352–1360).

  49. Jick H, Chamberlin DP, Hagberg KW. The origin and spread of a mumps epidemic: United kingdom, 2003–2006. Epidemiology. 2009;20(5):656–61.

    Article  PubMed  Google Scholar 

  50. Muhlemann K. The molecular epidemiology of mumps virus. Infect Genet Evol. 2004;4(3):215–19.

    Article  PubMed  Google Scholar 

  51. Bonnet MC, Dutta A, Weinberger C, Plotkin SA. Mumps vaccine virus strains and aseptic meningitis. Vaccine. 2006;24(49–50):7037–45.

    Article  CAS  PubMed  Google Scholar 

  52. World Health Organization. Mumps virus vaccines. Wkly Epidemiol Rec. 2007;82(7):51–60.

    Google Scholar 

  53. Stokes J Jr, Weibel RE, Buynak EB, Hilleman MR. Live attenuated mumps virus vaccine. II. Early clinical studies. Pediatrics. 1967;39(3):363–71.

    PubMed  Google Scholar 

  54. Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990–2003. Vaccine. 2008;26(9):1166–72.

    Article  CAS  PubMed  Google Scholar 

  55. Kaic B, Gjenero-Margan I, Aleraj B, Ljubin-Sternak S, Vilibic-Cavlek T, Kilvain S et al. Transmission of the L-Zagreb mumps vaccine virus, Croatia, 2005–2008. Euro Surveill. 2008;13(16). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18843.

    CAS  PubMed  Google Scholar 

  56. Tesovic G, Poljak M, Lunar MM, Kocjan BJ, Seme K, Vukic BT et al. Horizontal transmission of the Leningrad-Zagreb mumps vaccine strain: a report of three cases. Vaccine. 2008;26(16):1922–5.

    Article  PubMed  Google Scholar 

  57. Atrasheuskaya AV, Neverov AA, Rubin S, Ignatyev GM. Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus. Vaccine. 2006;24(10):1530–6.

    Article  CAS  PubMed  Google Scholar 

  58. Weibel RE, Stokes J Jr, Buynak EB, Whitman JE Jr, Hilleman MR. Live attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation. N Engl J Med. 1967;276(5):245–51.

    Article  CAS  PubMed  Google Scholar 

  59. Miller E, Goldacre M, Pugh S, Colville A, Farrington P, Flower A et al. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet. 1993;341(8851):979–82.

    Article  CAS  PubMed  Google Scholar 

  60. LeBaron CW, Forghani B, Beck C, Brown C, Bi D, Cossen C et al. Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis. 2009;199(4):552–60.

    Article  PubMed  Google Scholar 

  61. Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine. 1995;13(9):799–802.

    Article  CAS  PubMed  Google Scholar 

  62. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197(7):950–6.

    Article  PubMed  Google Scholar 

  63. Jokinen S, Osterlund P, Julkunen I, Davidkin I. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination. J Infect Dis. 2007;196(6):861–7.

    Article  CAS  PubMed  Google Scholar 

  64. Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine. 2005;23(31):4070–4.

    Article  CAS  PubMed  Google Scholar 

  65. Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis. 2007;45(4):459–66.

    Article  PubMed  Google Scholar 

  66. Beck M, Welsz-Malecek R, Mesko-Prejac M, Radman V, Juzbasic M, Rajninger-Miholic M et al. . Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials. J Biol Stand. 1989;17(1):85–90.

    Article  CAS  PubMed  Google Scholar 

  67. Vesikari T, Sadzot-Delvaux C, Rentier B, Gershon A. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine. Pediatr Infect Dis J. 2007;26(7):632–8.

    Article  PubMed  Google Scholar 

  68. Boxall N, Kubinyiova M, Prikazsky V, Benes C, Castkova J. An increase in the number of mumps cases in the Czech Republic, 2005–2006. Euro Surveill. 2008;13(16). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18842.

    CAS  PubMed  Google Scholar 

  69. Bernard H, Schwarz NG, Melnic A, Bucov V, Caterinciuc N, Pebody RG et al. . Mumps outbreak ongoing since October 2007 in the Republic of Moldova. Euro Surveill. 2008;13(13). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8079.

    CAS  Google Scholar 

  70. Kaaijk P, van der Zeijst B, Boog M, Hoitink C. Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype. Euro Surveill. 2008;13(26). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18914.

    CAS  PubMed  Google Scholar 

  71. Public Health Agency of Canada. Canadian National Report on Immunization, 2006. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/06vol32/32s3/4epi-eng.php

  72. Gay N, Miller E, Hesketh L, Morgan-Capner P, Ramsay M, Cohen B et al. Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule. Commun Dis Rep CDR Rev. 1997;7(2):R21–R26.

    CAS  PubMed  Google Scholar 

  73. Anderson RM, Crombie JA, Grenfell BT. The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization. Epidemiol Infect. 1987;99(1):65–84.

    Article  CAS  PubMed  Google Scholar 

  74. Colville A, Pugh S, Miller E. Withdrawal of a mumps vaccine. Eur J Pediatr. 1994;153(6):467–8.

    Article  CAS  PubMed  Google Scholar 

  75. Centers for Disease Control and Prevention. Mumps epidemic–United kingdom, 2004–2005. MMWR Morb Mortal Wkly Rep. 2006;55(7):173–5.

    Google Scholar 

  76. Savage E, Ramsay M, White J, Beard S, Lawson H, Hunjan R et al. Mumps outbreaks across England and Wales in 2004: observational study. BMJ. 2005;330(7500):1119–20.

    Article  PubMed  Google Scholar 

  77. MacDonald N, Flegel K. Mumps in young adults: the canary in the coal mine. CMAJ. 2007;177(2):121, 3.

    Google Scholar 

  78. Wright JA, Polack C. Understanding variation in measles-mumps-rubella immunization coverage–a population-based study. Eur J Public Health. 2006;16(2):137–42.

    Article  PubMed  Google Scholar 

  79. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N et al. . Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerg Infect Dis. 2007;13(1):12–17.

    PubMed  Google Scholar 

  80. Gabutti G, Guido M, Rota MC, De Donno A, Ciofi Degli Atti ML, Crovari P. The epidemiology of mumps in Italy. Vaccine. 2008;26(23):2906–11.

    Article  CAS  PubMed  Google Scholar 

  81. Public Health Agency of Canada. Mumps in Canada, 2007. 2009. http://www.phac-aspc.gc.ca/mumps-oreillons/prof-eng.php

  82. Goh KT. Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain. Lancet. 1999;354(9187):1355–6.

    Article  CAS  PubMed  Google Scholar 

  83. Ong G, Goh KT, Ma S, Chew SK. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population. J Infect. 2005;51(4):294–8.

    Article  PubMed  Google Scholar 

  84. Richard JL, Zwahlen M, Feuz M, Matter HC. Comparison of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 2000: a case-cohort study. Eur J Epidemiol. 2003;18(6):569–77.

    Article  PubMed  Google Scholar 

  85. Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis. 2008;46(8):1172–80.

    Article  PubMed  Google Scholar 

  86. Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ et al. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. J Infect Dis. 2008;198(4):508–15.

    Article  PubMed  Google Scholar 

  87. Narita M, Matsuzono Y, Takekoshi Y, Yamada S, Itakura O, Kubota M et al. Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G. Clin Diagn Lab Immunol. 1998;5(6):799–803.

    CAS  PubMed  Google Scholar 

  88. Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA. 2000;284(20):2643–7.

    Article  CAS  PubMed  Google Scholar 

  89. Centers for Disease Control and Prevention. Updated recommendations for isolation of persons with mumps. MMWR Morb Mortal Wkly Rep. 2008;57(40):1103–5.

    Google Scholar 

  90. Marienau KJ, Averhoff F, Redd S. The role of air travel in the spread of mumps. Clin Infect Dis. 2008;47(9):1237.

    Article  PubMed  Google Scholar 

  91. Centers for Disease Control and Prevention. Vaccines & Immunizations. Programs & Tools. CDC Vaccine Price List. 2009. http://www.cdc.gov/vaccines/programs/vfc/cdc-vac-price-list.htm

  92. Kamerow D. Yankee doodling: jabbering about jabs. BMJ. 2008;337:a1517.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatrics and Computer Science, Dalhousie University, Halifax, Canada

    Noni MacDonald

  2. Division of Pediatric Infectious Diseases, IWK Health Center, Halifax, Canada

    Noni MacDonald

  3. Division of Microbiology, Department of Pathology and Laboratory Medicine, CDHA and Dalhousie University, Halifax, Canada

    Todd Hatchette

  4. Pediatric Infectious Diseases, Dalhousie University, Halifax, Nova Scotia, Canada

    Lotfia Elkout

  5. Division of Pediatric Infectious Diseases, IWK Health Center, Halifax, Nova Scotia, Canada

    Lotfia Elkout

  6. Pictou County District Health Authorities, Colchester Regional Hospital, Truro, Canada

    Shelly Sarwal

Authors
  1. Noni MacDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Todd Hatchette
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lotfia Elkout
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shelly Sarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noni MacDonald .

Editor information

Editors and Affiliations

  1. Royal Children's Hospital, Dept. Pediatrics, University of Melbourne, Flemington Road, Parkville, 3052, Victoria, Australia

    Nigel Curtis

  2. Institute of Child Life and Health, UBHT Education Centre, University of Bristol, Upper Maudlin Street, Bristol, BS2 8AE, United Kingdom

    Adam Finn

  3. University of Oxford, Level 4,John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom

    Andrew J. Pollard

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

MacDonald, N., Hatchette, T., Elkout, L., Sarwal, S. (2011). Mumps is Back: Why is Mumps Eradication Not Working?. In: Curtis, N., Finn, A., Pollard, A. (eds) Hot Topics in Infection and Immunity in Children VII. Advances in Experimental Medicine and Biology, vol 697. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7185-2_14

Download citation

Publish with us

Policies and ethics

Search

Navigation